Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
February 13, 2023 at 16:55 PM EST
Madrigal Pharmaceuticals' resmetirom is a leading treatment candidate for the advanced form of fatty liver disease.
